Skip to main content
. 2025 Jun 16;16(8):e00873. doi: 10.14309/ctg.0000000000000873

Table 3.

Association of LHR, MHR, NHR, and LHR with the prevalence of significant liver fibrosis in US adults

Crude model OR (95% CI) P value Model 1 OR (95% CI) P value Model 2 OR (95% CI) P value
Log2(LHR) 1.840 (1.616–2.096) <0.0001 1.926 (1.691–2.193) <0.0001 1.570 (1.366–1.804) <0.0001
LHR quartile
 Q1 Ref. Ref. Ref.
 Q2 1.045 (0.643–1.700) 0.8593 1.115 (0.691–1.799) 0.6589 0.955 (0.577–1.581) 0.8601
 Q3 2.050 (1.570–2.677) <0.0001 2.194 (1.732–2.780) <0.0001 1.738 (1.384–2.181) 0.0001
 Q4 2.595 (1.915–3.516) <0.0001 2.839 (2.143–3.760) <0.0001 2.057 (1.508–2.805) 0.0002
P for trend <0.0001 <0.0001 <0.0001
 Log2(MHR) 1.883 (1.506–2.356) <0.0001 1.803 (1.383–2.349) 0.0001 1.425 (1.068–1.901) 0.0249
MHR quartile
 Q1 Ref. Ref. Ref.
 Q2 1.766 (1.250–2.496) 0.0027 1.719 (1.210–2.441) 0.0054 1.389 (0.957–2.016) 0.0992
 Q3 2.212 (1.455–3.361) 0.0007 2.078 (1.312–3.291) 0.0043 1.612 (0.990–2.624) 0.0694
 Q4 3.235 (2.184–4.792) <0.0001 2.956 (1.873–4.665) 0.0001 1.923 (1.167–3.166) 0.0183
P for trend <0.0001 0.0001 0.0244
 Log2(NHR) 1.855 (1.499–2.297) <0.0001 1.818 (1.422–2.323) <0.0001 1.396 (1.057–1.844) 0.0283
NHR quartile
 Q1 Ref. Ref. Ref.
 Q2 0.773 (0.524–1.140) 0.2015 0.760 (0.504–1.147) 0.2024 0.650 (0.425–0.994) 0.0609
 Q3 1.627 (1.208–2.191) 0.0028 1.582 (1.142–2.189) 0.0102 1.174 (0.825–1.669) 0.3832
 Q4 2.780 (1.983–3.897) <0.0001 2.644 (1.812–3.856) <0.0001 1.642 (1.072–2.516) 0.0337
P for trend <0.0001 <0.0001 0.0017
 Log2(PHR) 1.746 (1.397–2.182) <0.0001 1.823 (1.418–2.344) 0.0001 1.384 (1.057–1.813) 0.0276
PHR quartile
 Q1 Ref. Ref. Ref.
 Q2 0.969 (0.705–1.331) 0.8451 0.969 (0.708–1.327) 0.8469 0.761 (0.545–1.062) 0.1243
 Q3 1.329 (0.955–1.850) 0.1002 1.359 (0.983–1.880) 0.0741 0.995 (0.686–1.445) 0.9799
 Q4 2.273 (1.619–3.192) <0.0001 2.377 (1.635–3.455) 0.0001 1.527 (1.026–2.272) 0.0500
P for trend <0.0001 <0.0001 0.0121

CI, confidence interval; LHR, lipoprotein-cholesterol ratio; MHR, monocyte-HDL-C ratio; NHR, neutrophil-HDL-C ratio; OR, odds ratio; PHR, platelet-HDL-C ratio.

The crude model was not adjusted for any covariates. Model 1 was partially adjusted for age, sex, race/ethnicity, education level, poverty income ratio (PIR), and marital status, whereas Model 2 additionally adjusted for smoking, physical activity, dietary energy intake, diabetes, hypertension, and BMI in addition to Model 1.